Clinical Trial Update: Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Avastin with chemotherapy for RAS-mutant unresectable colorectal liver-limited metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Xu jianmin | Conditions: Colorectal Neoplasms | Phase 4 | Status: COMPLETED